Authors: de Mascarel, I Bonichon, F MacGrogan, G de Lara, CT Avril, A Picot, V Durand, M Mauriac, L Trojani, M Coindre, JM

Citation: I. De Mascarel et al., Application of the Van Nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examinated by serial macroscopic sectioning: Practical considerations, BREAST CANC, 61(2), 2000, pp. 151-159

Authors: Julien, JP Bijker, N Fentiman, IS Peterse, JL Delledonne, V Rouanet, P Avril, A Sylvester, R Mignolet, F Bartelink, H Van Dongen, JA

Citation: Jp. Julien et al., Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853, LANCET, 355(9203), 2000, pp. 528-533

Authors: Mauriac, L MacGrogan, G Avril, A Durand, M Floquet, A Debled, M Dilhuydy, JM Bonichon, F

Citation: L. Mauriac et al., Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: Aunicentre randomized trial with a 124-month median follow-up, ANN ONCOL, 10(1), 1999, pp. 47-52

Authors: Rudolph, P MacGrogan, G Bonichon, F Frahm, SO de Mascarel, I Trojani, M Durand, M Avril, A Coindre, JM Parwaresch, R

Citation: P. Rudolph et al., Prognostic significance of Ki-67 and topoisomerase II alpha expression in infiltrating ductal carcinoma of the breast - A multivariate analysis of 863 cases, BREAST CANC, 55(1), 1999, pp. 61-71